Repeated S-ketamine infusions in therapy resistant depression: A case series

Journal of Clinical Pharmacology

Volumn 53, Issue 9, 2013, Pages 996-998

  Segmiller, Felix ^a   Rüther, Tobias ^a   Linhardt, Andrea ^a   Padberg, Frank ^a   Berger, Michael ^a   Pogarell, Oliver ^a   Möller, Hans Jürgen ^a   Kohler, Christina ^b   Schüle, Cornelius ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b BKH Augsburg ^*  (Germany)

Author keywords

Analgesiology pain management (ANA); Clinical trials (CTR); Pharmacology (PHA); Psychiatry (PSY); Psychopharmacology (PSP)

Indexed keywords

AGOMELATINE; AMITRIPTYLINE; AMITRIPTYLINOXIDE; ANTIDEPRESSANT AGENT; DOXEPIN; ESKETAMINE; LAMOTRIGINE; LITHIUM; LORAZEPAM; MIRTAZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZOPICLONE;

ADULT; AGED; ANTIDEPRESSANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DISSOCIATIVE DISORDER; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; REMISSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANALGESIOLOGY/PAIN MANAGEMENT (ANA); CLINICAL TRIALS (CTR); PHARMACOLOGY (PHA); PSYCHIATRY (PSY); PSYCHOPHARMACOLOGY (PSP);

AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; MALE; MIDDLE AGED; OFF-LABEL USE; TREATMENT OUTCOME;

EID: 84885066566     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/jcph.122     Document Type: Article

References (8)

1. Berman RM, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351- 354. (Pubitemid 30109248)
2. Zarate CA Jr., Singh JB, Carlson PJ, et al. A randomized trial of an Nmethyl- D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856-864. (Pubitemid 44188478)
3. Aan Het Rot M, Zarate CA Jr, Charney DS, Mathew SJ. Ketamine for depression: where do we go from here? Biol Psychiatry. 2012;72 (7):537-547.
4. Paul R, Schaaff N, Padberg F, Moller HJ, Frodl T. Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases.World J Biol Psychiatry. 2009;10(3):241-244.
5. aan het Rot M, Collins KA, Murrough JW, et al. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry. 2010;67(2):139-145.
6. Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, Aan Het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2012. [Epub ahead of print]. doi: 10.1016/j.biopsych.2012.06.022.
7. Mathew SJ, Murrough JW, aan het Rot M, Collins KA, Reich DL, Charney DS. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: A pilot randomized, placebo-controlled continuation trial. Int J Neuropsychopharmacol. 2010;13(1):71-82. Epub 2009 Mar 17.
8. Morgan CJ, Muetzelfeldt L, Curran HV. Ketamine use, cognition and psychological wellbeing: A comparison of frequent, infrequent and exusers with polydrug and non-using controls. Addiction. 2009;104 (1):77-87.